Application of technetium-99m-sestamibi in differentiation of active from inactive pulmonary tuberculosis using a single photon emission computed tomography method

Nuclear Medicine Communications

Volumn 29, Issue 8, 2008, Pages 690-694

  Ahmadihosseini, Hossein ^a   Sadeghi, Ramin ^a   Zakavi, Rasoul ^a   Kakhki, Vahid Reza Dabbagh ^a   Kakhki, Amirreza Haghighi ^a  

^a Pulmonary Disease Department   (Iran)

Author keywords

Pulmonary tuberculosis; Single photon emission computed tomography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPUTUM CULTURE; STATISTICAL SIGNIFICANCE; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUBERCULOSIS, PULMONARY;

EID: 55249098632     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283009f22     Document Type: Article

References (36)

1. Teixeira HC, Abramo C, Munk ME. Immunological diagnosis of tuberculosis: problems and strategies for success. J Bras Pneumol 2007; 33:323-334.
2. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007; 369:2042-2049.
3. Wolinsky E. Conventional diagnostic methods for tuberculosis. Clin Inject Dis 1994; 19:397-401.
4. Van Den Brande P, Demedts M. Pulmonary tuberculosis in the elderly: diagnostic difficulties. Eur J Med 1992; 1:224-229.
5. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4:97-107.
6. Miller WT, Miller WT Jr. Tuberculosis in the normal host: radiological findings. Semin Roentgenol 1993; 28:109-118.
7. Good RC, Mustro TD. The modern mycobacteriology laboratory: how it can help the clinician. Clin Chest Med 1989; 10:315-322.
8. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007; 131:1898-1906.
9. Harries A, Banda H, Boeree M. Management of pulmonary tuberculosis suspects with negative sputum smears and normal or minimally abnormal chest radiographs in resource-poor settings. Int J Tuberc Lung Dis 1998; 2:999-1004.
10. Kao CH, Wang SJ, Liao SQ, Lin WY, Hsu CY. Usefulness of gallium-67-citrate scans in patients with acute disseminated tuberculosis and comparison with chest X-rays. J Nucl Med 1993; 34:1918-1921.
11. Liu SF, Liu JW, Lin MC, Lee CH, Huang HH, Lai YF. Monitoring treatment responses in patients with pulmonary TB using serial lung gallium-67 scintigraphy. Am J Roentgenol 2007; 188:403-408.
12. Utsinomiya K, Narabayashi I, Nishigaki H, Tsujitomo K, Kariyone S, Ohnishi S. Clinical significance of thallium-201 and gallium-67 scintigraphy in pulmonary tuberculosis. Eur J Nucl Med 1997; 24:252-257.
13. Iwata T, Inoue K, Mizuguchi S, Tsukioka T, Morita R, Suehiro S. Thymic tuberculosis preoperatively evaluated with thallium-201 SPECT: two resected cases. Ann Thorac Cardiovasc Surg 2007; 13:44-46.
14. Lee JD, Shin KH, Cho SN, Shin JS, Lee MG, Yang WI, et al. Immunoscintigraphy in the detection of tuberculosis with radiolabeled antibody fragment against Mycobacterium bovis bacillus Calmette-Guérin, a preliminary study in a rabbit model. Eur J Nucl Med 1992; 19:1011-1015.
15. Vorne M, Sahlström K, Alanko K. Poor accumulation of technetium-99m-glucoheptonate in sarcoidosis and other diffuse infiltrative lung diseases as compared with gallium-67-citrate. Clin Nucl Med 1988; 13:107-109.
16. Passamonte PM, Seger RM, Holmes RA, Hurst D. Technetium-99m-glucoheptonate imaging in lung cancer and benign lung diseases concise communication. J Nucl Med 1983; 24:997-1000.
17. Vanhagen PM, Krenning EP, Reubi JC, Kwekkeboom DJ, Bakker WH, Mulder AH, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 1994; 21:497-502.
18. Tabuenca DO, Gutiérrez MC, Rego IA. Incidental diagnosis of lymph node tuberculosis in an 111-indium-octreotide scintigraphy during a study of acromegaly. Rev Esp Med Nucl 2006; 25:193-197.
19. 99mTc (V) DMSA and Tc-99m citrate in comparison to Ga-67 citrate. Clin Nucl Med 1995;20:1012-1014.
20. Wang HY, Lin WY. Jejunal tuberculosis: incidental finding on an FDG-PET scan. Kaohsiung J Med Sci 2006; 22:34-38.
21. Enomoto K, Hoshida Y, Hamada K, Okada T, Kubo T, Hatazawa J. F-18 FDG PET imaging of cervical tuberculous lymphadenitis. Clin Nucl Med 2007; 32:474-475.
22. Sergieva S, Hadjieva T, Doldurova M, Stefanova S, Dudov A. Nuclear medicine approaches in the monitoring of thyroid cancer patients. J BUON 2006; 11:511-518.
23. 99mTc-MIBI uptake correlate with P-glycoprotein expression in lung cancer. Nucl Med Commun 2007; 28:696-703.
24. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m-rnethoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994; 2:432-436.
25. Aktolun C, Demirel D, Kir M, Bayhan H, Maden HA. Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis. J Nucl Med 1991; 32:1429-1431.
26. Caner B, Kitapci M, Unlu M. Technetium-99m-MIBI uptake in benign and malignant bone lesions' a comparative study with technetium-99m-MDP. J Nucl Med 1992; 33:319-324.
27. Sobic-Saranovic DP, Pendjer IP, Kozarevic NDj, Artiko VM, Mikic AA, Obradovic VB. Evaluation of undifferentiated carcinoma of nasopharyngeal type with thallium-201 and technetium-99m MIBI SPECT. Otolaryngol Head Neck Surg 2007; 137:405-411.
28. 99mTc-tetrofosmin scintigraphy in management of pulmonary tuberculosis. J Nucl Med 2000; 41:1120.
29. Bennink R, Drieskens O, Drieskens L, Kebooms L. Tc-99m tetrofosmin uptake in pulmonary tuberculosis with Pott's disease. Clin Nucl Med 1998; 23:851-853.
30. Degirmenci B, Kilinc O, Cirak KA, Capa G, Akpinar O, Halilcolar H, et al. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis. J Nucl Med 1998; 39:2116-2120.
31. 99mTc tetrofosmin biophysical localization mechanisms. Rev Med Chir Soc Med Nat Iasi 2006; 110:944-949.
32. 99mTc MIBI cellular uptake mechanism. Rev Med Chir Soc Med Nat Iasi 2007; 111:210-215.
33. Önsel C, Sönmezoglu K, Camsari G, Atay S, Cetin S, Erdil YT, et al. Technetium-99m-MIBI scintigraphy in pulmonary tuberculosis. J Nucl Med 1996; 37:233-238.
34. Kim SM, Bom HS, Song HC, Jeong HJ, Min JJ, Li MH, et al. Focal pulmonary uptake during Tc-99m myocardial perfusion SPECT imaging. Clin Nucl Med 2001; 26:913-915.
35. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30:301-311.
36. Zakavi SR. Nuclear cardiology in Iran in 2002. Iranian J Nucl Med 2003; 21:73-77.